Pharmaceutical drug testing is the meticulous exploration of a compound's safety, efficacy, and potential side effects, marking a pivotal phase in the journey from discovery to market. This intricate process unfolds in a series of carefully designed trials, each serving a distinct purpose in unravelling the compound's impact on the human body. The journey begins with preclinical testing, where researchers delve into the compound's behaviour in the laboratory and animal models. This phase unveils insights into safety profiles, potential dosage ranges, and initial efficacy.
Upon successful preclinical evaluations, the compound progresses to clinical trials, a multi-phase endeavour involving human subjects. Phase 1 focuses on safety and dosage, Phase 2 delves into efficacy, and Phase 3 expands to larger populations, further validating the drug's effectiveness and monitoring for rare side effects. Regulatory bodies meticulously review the accumulated data, assessing the compound's risk-benefit profile before granting approval for market release. Post-marketing surveillance continues the scrutiny, ensuring ongoing safety and efficacy monitoring.
The evolution of pharmaceutical drug testing mirrors a meticulous orchestration of scientific inquiry, ethical considerations, and regulatory diligence. Each trial, from petri dish to patient, contributes to the collective endeavour of bringing safe and effective medications to those in need.
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Exploring classical ayurvedic drugs in hypertension
Prashant Bhokardankar, Datta Meghe Ayurved College, India
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : A unique role and and impact of catalytic antibodies (abzymes) in clinical practice: A novel strategy for predicting and preventing relapse in chronic autoimmune conditions
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : The promise of nanotechnology in personalized & precision medicine: Drug discovery & development being partnered with nanotechnologies via the revolution at the nanoscale
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : The promising future of the unique translational tool to manage beta-cell population renewal and regeneration to secure the post-diabetic period
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Easily injectable, organic solvent free self assembled hydrogel platform for endoscope mediated gastrointestinal polypectomy
Hitasha Vithalani , IIT Gandhinagar, India